Atlas Trials

Adult Attention Deficit Hyperactivity Disorder

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Adult Attention Deficit Hyperactivity Disorder

RecordFirmDate
The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder (NCT03324581)Otsuka Pharmaceutical Development & Commercialization, Inc.2017-11-09
Clinical and Suicidal Features of Urban, Turkish Middle Age Depressive Patients With Comorbid ADHD (NCT03721588)Bozyaka Training and Research Hospital2015-09-01
Dasotraline Adult ADHD Study (NCT02276209)Sumitomo Pharma America, Inc.2014-12-01
Open-label Safety Study in Adults With ADHD (NCT02160262)Sumitomo Pharma America, Inc.2014-06-01
Adult Attention Deficit Hyperactivity Disorder (NCT01692782)Sumitomo Pharma America, Inc.2012-12-01
Essential Fatty Acids in Adult ADHD (NCT01798381)Universität des Saarlandes2012-12-01
Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65). (NCT02141113)Rochester Center for Behavioral Medicine2012-11-01
Integrated Diagnosis and Treatment of Adults With Attention-deficit/Hyperactivity Disorder (NCT01615679)Medice Arzneimittel Pütter GmbH & Co KG2012-08-01
Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence (NCT00553319)New York State Psychiatric Institute2007-12-01

Track Adult Attention Deficit Hyperactivity Disorder automatically

Every clearance here is in the API, with alerts when new ones post.